An asthma medication improves asthma control, respiratory quality of life, and upper airway symptoms in patients with chronic ...

Clinical trial datasets are becoming increasingly complex, yet the format of their dissemination remains largely static.1 ...

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will present new ...

The results of the EVOKE and EVOKE+ trials were comprehensive in showing oral semaglutide’s lack of clinical efficacy for cognition or function in patients with early Alzheimer’s.

Long-term lithium therapy remains the most effective maintenance treatment for bipolar disorder, yet it poses a significant risk of progressive renal impairment in a subset of patients. Early ...

It's said that statistics don't lie, but they often don't tell the whole truth, either. A Cornell statistics expert has come up with a method he believes can boost statistical power and significantly ...

Researchers conducted a systematic review and meta-analysis to evaluate the efficacy of immune-inflammatory indices for predicting acute gout attacks.

Two multicenter trials drew different conclusions about the value of conduction system relative to biventricular pacing for left bundle branch block in heart failure.

There was some evidence that cannabinoids can reduce symptoms of cannabis use disorder, insomnia, tic or Tourette's syndrome, and autism spectrum disorder, but the quality of this evidence was ...

Elevated blood pressure (hypertension) is a leading, preventable risk factor for heart disease. Nicotinamide mononucleotide (NMN) supplementation may help lower blood pressure. Researchers discovered ...

Postdischarge adverse drug event risk is amplified by frequent medication changes, formulary substitutions, and insurance coverage gaps, with wide variability in published incidence estimates and ...

As a potential biomarker of treatment response, ctDNA and utDNA analyses were performed before systemic therapy, at restaging, and for responders at the beginning of adjuvant nivolumab. ctDNA was ...